Consortium wins EU grant to develop new leishmaniasis drug

Professor Sanjeev Krishna and colleagues are heading a consortium that has been awarded EUR3.75 million to develop a treatment for one of the world’s most neglected tropical diseases, leishmaniasis.

The funding is for full development of an exciting treatment prospect that has already shown promise in laboratory studies.


Artemisinins still our best weapon against malaria, say experts

The powerful medicines known as artemisinins have plenty of mileage in them in the global fight against malaria, and concern about partial resistance has been overstated.

That’s the message in a piece published today by scientists and doctors to coincide with World Malaria Day.

malaria

Doctors begin new clinical trial treating cancer with 70p malaria drug

Experts from St George’s University of London, and St George’s Hospital have joined forces to investigate whether a common and cheap malaria drug can be used also against cancer.

7 March 2017


St George’s to provide TB expertise to a Bill & Melinda Gates Foundation funded project

St George’s, University of London, will be directly collaborating in a far-reaching project with longstanding commercial partner QuantuMDx to further develop and test its diagnostic technologies for tuberculosis, which causes nearly three deaths every minute.

2 December 2016


World Malaria Day video

St George's, University of London Principal, Professor Jenny Higham speaks to malaria expert Professor Sanjeev Krishna marking World Malaria Day and the work we are doing to tackle this global health problem.

Watch the video on the St George's YouTube channel